Literature DB >> 15911749

Molecular engineering human hepatocytes into pancreatic beta cells for diabetes therapy.

Irene Cozar-Castellano1, Andrew F Stewart.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15911749      PMCID： PMC1142398          DOI： 10.1073/pnas.0503261102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  9 in total

1.  Medicine. Gene therapy--new challenges ahead.

Authors:  David A Williams; Christopher Baum
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

Review 2.  Minireview: transcriptional regulation in pancreatic development.

Authors:  Joel F Habener; Daniel M Kemp; Melissa K Thomas
Journal:  Endocrinology       Date:  2004-12-16       Impact factor: 4.736

3.  NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice.

Authors:  Hideto Kojima; Mineko Fujimiya; Kazuhiro Matsumura; Patrick Younan; Hirotsugu Imaeda; Makiko Maeda; Lawrence Chan
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

4.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Authors:  A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

5.  Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence.

Authors:  D A Stoffers; N T Zinkin; V Stanojevic; W L Clarke; J F Habener
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

Review 6.  Pancreas transplantation: indications and consequences.

Authors:  Jennifer L Larsen
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

7.  Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells.

Authors:  Tamar Sapir; Keren Shternhall; Irit Meivar-Levy; Tamar Blumenfeld; Hamutal Cohen; Ehud Skutelsky; Smadar Eventov-Friedman; Iris Barshack; Iris Goldberg; Sarah Pri-Chen; Lya Ben-Dor; Sylvie Polak-Charcon; Avraham Karasik; Ilan Shimon; Eytan Mor; Sarah Ferber
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-17       Impact factor: 11.205

8.  PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance.

Authors:  Rohit N Kulkarni; Ulupi S Jhala; Jonathon N Winnay; Stan Krajewski; Marc Montminy; C Ronald Kahn
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

9.  Insulin-promoter-factor 1 is required for pancreas development in mice.

Authors:  J Jonsson; L Carlsson; T Edlund; H Edlund
Journal:  Nature       Date:  1994-10-13       Impact factor: 49.962
  9 in total
  3 in total

1.  Altered insulin receptor signalling and β-cell cycle dynamics in type 2 diabetes mellitus.

Authors:  Franco Folli; Terumasa Okada; Carla Perego; Jenny Gunton; Chong Wee Liew; Masaru Akiyama; Anna D'Amico; Stefano La Rosa; Claudia Placidi; Roberto Lupi; Piero Marchetti; Giorgio Sesti; Marc Hellerstein; Lucia Perego; Rohit N Kulkarni
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

Review 2.  Alpha-to-beta cell trans-differentiation for treatment of diabetes.

Authors:  Mohamed Saleh; George K Gittes; Krishna Prasadan
Journal:  Biochem Soc Trans       Date:  2021-12-17       Impact factor: 5.407

3.  Expansion of multipotent stem cells from the adult human brain.

Authors:  Wayne Murrell; Emily Palmero; John Bianco; Biljana Stangeland; Mrinal Joel; Linda Paulson; Bernd Thiede; Zanina Grieg; Ingunn Ramsnes; Håvard K Skjellegrind; Ståle Nygård; Petter Brandal; Cecilie Sandberg; Einar Vik-Mo; Sheryl Palmero; Iver A Langmoen
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.